EDP Sciences logo
Authentification abonné
rechercher
Menu
Accueil Tous les numéros Therapie, 65 3 (2010) 255-259 Article's citations

Article cité par

La fonctionnalité Article cité par… liste les citations d'un article. Ces citations proviennent de la base de données des articles de EDP Sciences, ainsi que des bases de données d'autres éditeurs participant au programme CrossRef Cited-by Linking Program. Vous pouvez définir une alerte courriel pour être prévenu de la parution d'un nouvel article citant " cet article (voir sur la page du résumé de l'article le menu à droite).

Article cité :

EPRCN exerts neuroprotective function by regulating gut microbiota and restoring gut immune homeostasis in Alzheimer's disease model mice

Ming-Jie Li, Meng-Ning Lan, Yao-Xuan Du, Yue Liu, Hua-Yue Zhang, Min Guo, Shi-Wei Liu, Hai-Yang Xia, Zheng-Jun Wu and Hua-Jun Zheng
Journal of Alzheimer’s Disease 106 (1) 151 (2025)
https://doi.org/10.1177/13872877251339762

Adverse event profile of memantine and donepezil combination therapy: a real-world pharmacovigilance analysis based on FDA adverse event reporting system (FAERS) data from 2004 to 2023

Yihan Yang, Sheng Wei, Huan Tian, Jing Cheng, Yue Zhong, Xiaoling Zhong, Dunbing Huang, Cai Jiang and Xiaohua Ke
Frontiers in Pharmacology 15 (2024)
https://doi.org/10.3389/fphar.2024.1439115

Combining donepezil and memantine via mannosylated PLGA nanoparticles for intranasal delivery: Characterization and preclinical studies

Mayank Handa, Sachin Nashik Sanap, Rabi Sankar Bhatta, Gajanan Pratap Patil, Suchetana Ghose, Dhirendra Pratap Singh and Rahul Shukla
Biomaterials Advances 154 213663 (2023)
https://doi.org/10.1016/j.bioadv.2023.213663

Advances in the Study of the Pathology and Treatment of Alzheimer’s Disease and Its Association with Periodontitis

Dan Tang, Chang Sun, Jumei Yang, Lili Fan and Yonggang Wang
Life 13 (11) 2203 (2023)
https://doi.org/10.3390/life13112203

Simultaneous Intranasal Codelivery of Donepezil and Memantine in a Nanocolloidal Carrier: Optimization, Pharmacokinetics, and Pharmacodynamics Studies

Mayank Handa, Sachin Nashik Sanap, Rabi Sankar Bhatta, Gajanan Pratap Patil, Rajendra Palkhade, Dhirendra Pratap Singh and Rahul Shukla
Molecular Pharmaceutics 20 (9) 4714 (2023)
https://doi.org/10.1021/acs.molpharmaceut.3c00454

Acetylcholinesterase Inhibitors: Beneficial Effects on Comorbidities in Patients With Alzheimer’s Disease

Vinod Kaushik, Sarah Toombs Smith, Emmanuel Mikobi and Mukaila A. Raji
American Journal of Alzheimer's Disease & Other Dementias® 33 (2) 73 (2018)
https://doi.org/10.1177/1533317517734352

Adverse Drug Reactions Reported With Cholinesterase Inhibitors

Edeltraut Kröger, Marie Mouls, Machelle Wilchesky, Mieke Berkers, Pierre-Hugues Carmichael, Rob van Marum, Patrick Souverein, Toine Egberts and Marie-Laure Laroche
Annals of Pharmacotherapy 49 (11) 1197 (2015)
https://doi.org/10.1177/1060028015602274

Screening for Cognitive Impairment in Older Adults: A Systematic Review for the U.S. Preventive Services Task Force

Jennifer S. Lin, Elizabeth O’Connor, Rebecca C. Rossom, Leslie A. Perdue and Elizabeth Eckstrom
Annals of Internal Medicine 159 (9) 601 (2013)
https://doi.org/10.7326/0003-4819-159-9-201311050-00730

Deterioration in donepezil-induced PR prolongation after a coadministration of memantine in a patient with Alzheimer's disease

Hirofumi Igeta, Yutaro Suzuki, Takaharu Motegi, et al.
General Hospital Psychiatry 35 (6) 680.e9 (2013)
https://doi.org/10.1016/j.genhosppsych.2013.04.007

Les médicaments à visée anti-Alzheimer favorisent-ils la survenue de crises d’épilepsie ? Discussion à propos de 3 cas cliniques

Michel Roy, Karine Castro-Lionard, Emilie Crawford-Achour, et al.
Therapies 66 (3) 291 (2011)
https://doi.org/10.2515/therapie/2011038